1. Pulmonary Alveolar Proteinosis in Association with Secondary Hemophagocytic Lymphohistiocytosis.
- Author
-
Lin J, De A, Figueiredo L, Maxwell R, Wasserman E, Adams K, Weingarten J, Peek G, and Miksa M
- Subjects
- Abnormalities, Multiple diagnosis, Abnormalities, Multiple therapy, Biopsy, Needle, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Immunohistochemistry, Infant, Lymphohistiocytosis, Hemophagocytic complications, Pulmonary Alveolar Proteinosis complications, Radiography, Thoracic methods, Rare Diseases, Respiration, Artificial, Respiratory Insufficiency diagnosis, Respiratory Insufficiency etiology, Respiratory Insufficiency therapy, Risk Assessment, Severity of Illness Index, Tomography, X-Ray Computed methods, Tracheostomy methods, Treatment Outcome, Lymphohistiocytosis, Hemophagocytic diagnosis, Lymphohistiocytosis, Hemophagocytic therapy, Pulmonary Alveolar Proteinosis diagnosis, Pulmonary Alveolar Proteinosis therapy
- Abstract
Pulmonary alveolar proteinosis (PAP) is a rare diffuse lung disease in the pediatric population. There are currently few cases documenting hemophagocytic lymphohistiocytosis as a cause for secondary PAP. We describe an ex-preterm child with secondary hemophagocytic lymphohistiocytosis, complicated by PAP and hypoxemic respiratory failure., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF